- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00768794
Acidophilus for the Treatment and Prevention of Oral Candidiasis in Patients Undergoing Radiation Therapy
A Trial Using Acidophilus for the Treatment and Prevention of Oral Candidiasis in Head and Neck Cancer Patients Undergoing Radiation Therapy
The purpose of this study is to determine the effectiveness of using acidophilus to treat oral candidiasis (thrush) caused by radiation therapy to the head and neck region.
This study will conducted in two parts. In the first part of the study, two participants will begin radiation therapy. When signs and symptoms of thrush are noted, such as smooth, creamy, white/yellow coating and/or patches on the tongue and inside of your mouth that are painful, you will begin taking acidophilus capsules twice each day until the last day of radiation therapy.
The second part of the study is to determine if acidophilus is effective in preventing oral candidiasis (thrush) during radiation therapy to the head and neck region. In the second part of the study three participants will take acidophilus capsules twice each day beginning on the first day of radiation therapy and continuing until the last day of radiation therapy.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
To determine if Lactobacillus acidophilus ,Ritzman Natural Health Acidophilus supplements given twice daily during radiation treatments to the head and neck region after the development of oral thrush is an effective treatment for oral candidiasis.
To determine if Lactobacillus acidophilus ,Ritzman Natural Health Acidophilus supplements given twice daily beginning on the first day of radiation treatments to the head and neck region prevents the development of oral thrush.
To assess subjective and objective response of oral candidiasis treated with Lactobacillus acidophilus ,Ritzman Natural Health Acidophilus supplements.
To assess the efficacy of Lactobacillus acidophilus ,Ritzman Natural Health Acidophilus supplements in preventing oral candidiasis in patients receiving radiation therapy to the head and neck region.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Akron, Ohio, United States, 44304
- Summa Health System
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pathologically (histologically or cytologically) proven diagnosis of squamous cell carcinoma of the head and neck region receiving > 50 Gy to head and neck tumor with or without concomitant chemotherapy and/or cetuximab.
- Age ≥ 18
- Karnofsky Performance Score of > 70
- History and physical examination within 8 weeks prior to registration
- Patient must sign study specific informed consent prior to study entry.
Exclusion Criteria:
- Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years.
- Patients with carcinoma in-situ of the breast, oral cavity, or cervix are eligible.
- Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields.
- Acute bacterial or fungal infection requiring intravenous or oral antibiotics at study entry
- Sjoren's syndrome
- Hypoadrenalism
- Acquired Immune Deficiency Syndrome (AIDS) based upon current CDC definition; note, however, that HIV testing is not required for entry into this protocol.
- Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception.
- Prior allergic reaction to Lactobacillus acidophilus.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Acidolphilus
In the first part of the study, two participants will begin radiation therapy.
When signs and symptoms of thrush are noted, such as smooth, creamy, white/yellow coating and/or patches on the tongue and inside of their mouth that are painful, subjects will begin taking acidophilus capsules twice each day until the last day of radiation therapy.
|
Use of Acidophilus in the first part of the study, two participants will begin radiation therapy. When signs and symptoms of thrush are noted, such as smooth, creamy, white/yellow coating and/or patches on the tongue and inside of their mouth that are painful, subjects will begin taking acidophilus capsules twice each day until the last day of radiation therapy. The second part of the study is to determine if acidophilus is effective in preventing oral candidiasis (thrush) during radiation therapy to the head and neck region.
The second part of the study is to determine if acidophilus is effective in preventing oral candidiasis (thrush) during radiation therapy to the head and neck region.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To determine if Lactobacillus acidophilus ,Ritzman Natural Health Acidophilus supplements given twice daily during radiation treatments to the head and neck region after the development of oral thrush is an effective treatment for oral candidiasis.
Time Frame: during duration of treatment of 4 weeks.
|
during duration of treatment of 4 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To the response of oral candidiasis treated with Lactobacillus acidophilus ,Ritzman Natural Health Acidophilus supplements and to determine efficacy.
Time Frame: during duration of treatment of 4 weeks.
|
during duration of treatment of 4 weeks.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Heather Tharpe, Rn, BSN, OCN, Summa Health System
- Study Director: Joyce Neading, RHIT, CTR, Summa Health System
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Acidophilus
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Candidiasis
-
University of FloridaTerminatedHIV Infections | CandidiasisUnited States
-
Raphael Freitas de SouzaCompletedOral Hygiene | Dental Plaque | Oral Candidiasis | Denture StomatitisBrazil
-
University of Santiago de CompostelaNot yet recruitingMicrobial Colonization | Oral Candidiasis | Xerostomia | Radiotherapy; Complications | Candida Albicans Infection | Oral Candidiasis RecurrentSpain
-
Raphael Freitas de SouzaFundação de Amparo à Pesquisa do Estado de São PauloCompletedOral Hygiene | Dental Plaque | Oral Candidiasis | Denture StomatitisBrazil
-
Hadassah Medical OrganizationCompletedOral Candidiasis | Denture StomatitisIsrael
-
Hams Hamed AbdelrahmanActive, not recruiting
-
Yasmine gamilCompleted
-
University of BelgradeRecruiting
-
Federal University of the Valleys of Jequitinhonha...UnknownOral Hygiene | Candidiasis, Oral | Behavior | NewbornsBrazil
-
Shahid Sadoughi University of Medical Sciences...CompletedBreastfeeding | Bottle Feeding | Oral CandidaIran, Islamic Republic of
Clinical Trials on Acidophilus
-
Dharmais National Cancer Center HospitalCompletedColorectal CancerIndonesia
-
Vancouver Island Health AuthorityCanadian Society of Hospital Pharmacists; Jamieson Laboratories Ltd, CanadaTerminatedDiarrhea | Clostridium DifficileCanada
-
DaniscoAlmarai; Clinart InternationalTerminatedIrritable Bowel SyndromeSaudi Arabia
-
DaniscoCompleted
-
Huaqiu ZhangNot yet recruitingIschemia | Cognitive Impairment | Cerebrovascular Ischemia
-
Huaqiu ZhangNot yet recruitingCognitive Impairment | Ischemia; Cerebrovascular
-
Qilu Hospital of Shandong UniversityNot yet recruiting
-
Anahuac UniversityNot yet recruitingDiabetes Mellitus | Cognition Disorders | Microbiome
-
University of CopenhagenCompletedSynbiotics | Healthy Humans | Composition of Gut Microbiota | Short and Branched-chain Fatty AcidsDenmark
-
Rigshospitalet, DenmarkRoyal Veterinary and Agricultural University, DenmarkUnknown